RE-PLY

Welcome to the Brand page for “RE-PLY”, which is offered here for Reply;medical services, provision of medical and pharmaceutical information via the internet;conducting clinical trials of pharmaceutical products;.

Its status is currently believed to be active. Its class is unavailable. “RE-PLY” is believed to be currently owned by “Boehringer Ingelheim International GmbH”.


Owner:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Owner Details
Description:
REPLY;Medical services, provision of medical and pharmaceutical information via the internet;Conducting clinical trials of pharmaceutical products;
Categories: REPLY